Evidence map›Paper›PMID 29637070›Full record

ArticleFrontiers in bioengineering and biotechnology2018

Lack of Detection of Bt Sugarcane Cry1Ab and NptII DNA and Proteins in Sugarcane Processing Products Including Raw Sugar.

Adriana Cheavegatti-Gianotto, Agustina Gentile, Danielle Angeloni Oldemburgo, Graciela do Amaral Merheb, Maria Lorena Sereno, Ron Peter Lirette, Thais Helena Silva Ferreira, Wladecir Salles de Oliveira

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Adriana Cheavegatti-GianottoRegulatory Department, Centro de Tecnologia Canavieira (CTC), Piracicaba, Brazil.
Agustina GentileBiotechnology Department, Centro de Tecnologia Canavieira (CTC), Piracicaba, Brazil.
Danielle Angeloni OldemburgoRegulatory Department, Centro de Tecnologia Canavieira (CTC), Piracicaba, Brazil.
Graciela do Amaral MerhebRegulatory Department, Centro de Tecnologia Canavieira (CTC), Piracicaba, Brazil.
Maria Lorena SerenoRegulatory Department, Centro de Tecnologia Canavieira (CTC), Piracicaba, Brazil.
Ron Peter LiretteRon Lirette Biotech Consulting LLC, Theriot, LA, United States.
Thais Helena Silva FerreiraBiotechnology Department, Centro de Tecnologia Canavieira (CTC), Piracicaba, Brazil.
Wladecir Salles de OliveiraRegulatory Department, Centro de Tecnologia Canavieira (CTC), Piracicaba, Brazil.
Sugarcane Research Center (Brazil) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazil is the largest sugarcane producer and the main sugar exporter in the world. The industrial processes applied by Brazilian mills are very efficient in producing highly purified sugar and ethanol. Literature presents evidence of lack of DNA/protein in these products, regardless of the nature of sugarcane used as raw material. Recently CTNBio, the Brazilian biosafety authority, has approved the first biotechnology-derived sugarcane variety for cultivation, event CTC175-A, which expresses the Cry1Ab protein to control the sugarcane borer (

Indexed as

Cry1Abhighly purified substanceneomycin-phosphotransferase type IIsugarsugarcane

Identifiers

PMID29637070
PMCPMC5880997
OpenAlexW2794551285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.